Anti-Inflammatory Research & Therap

Anti-Inflammatory Research & Therapeutics Conference - Register now to save 10%
От кого: "Modern Drug Discovery & Development Summit"
Кому: [e-mail]

28 июля, 18:58
If you can't view this page, please visit:http://www.gtcbio.com/newsletter/airt15II -w.htm GXOY-2866

5 presentations we don't want you to miss!
Anti-Inflammatory Research & Therapeutics Conference
September 10-11, 2015 | Loews Philadelphia Hotel | Philadelphia, PA
Speakers | Agenda | Venue | Submit an Abstract | Register

Dear Colleague,

The Anti-Inflammatory Research & Therapeutics Conference is happening soon onSeptember 10-11, 2015 in Philadelphia, PA. We have designed a comprehensive program that will cover hot topics in the field including understanding the pathways and mechanisms involved in inducing inflammation.

Here are some talks from the agenda:
Keynote Presentation - The Anti-Tumor Effects of the HMGN1 Alarmin
Joost Oppenheim, Chief of Laboratory of Molecular Immunoregulation at NCI, NIH
Recent studies have identified a group of structurally diverse multifunctional host proteins that are rapidly released following pathogen challenge or cell injury and are able to both chemotactically recruit and activate dendritic antigen-presenting cells. Dr. Oppenheim will discuss these potent immunostimulants, called alarmins, that serve as early warning signals to activate innate and adaptive immune systems.

Featured Presentation - STING- Dependent Innate Immune Signaling and Role in Inflammatory Disease and Cancer
Glen Barber, Chairman & Professor of Cell Biology of the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine
The focus of this presentation will center on STING (stimulator of interferon genes), which controls signaling and protects the host from disease, and its potential to battle against cancer and DNA-mediated inflammation.

IDO Pathway of Immunomodulation in Cancer and Cancer Therapy
George Prendergast, Professor, President & CEO of the Lankenau Institute for Medical Research
This talk discusses studies of indoleamine 2,3-dioxygenase (IDO) inhibitors as powerful immunomodulators to leverage the efficacy of immune checkpoint therapy, radiotherapy or chemotherapy, triggering regression of aggressive tumors otherwise resistant to treatment.

A Foe No More: Reprogramming NF-?B-Driven Inflammation in Cancer Therapy
Pawel Kalinski, Professor of Surgery and Director of the Immunotransplantation Center at the University of Pittsburgh
Dr. Kalinski will discuss different NF-?B-inducible tumor-promoting and anti-tumor inflammatory pathways and different strategies for their separation, in order to achieve optimal antitumor effects.

Bile Acid Regulation of the C3 Alternative Activation Pathway
Glenn Gerhard, Professor & Chair of Medical Genetics & Molecular Biochemistry at Temple University School of Medicine
Bile acids are emerging as key mediators of the beneficial metabolic effects from bariatric surgery. Dr. Gerhard will discuss using a serum proteomic approach to identify the complement component system that appears to play dual roles in inflammation and metabolism.
Session topics include:
Novel Targets in Inflammatory Cytokine Action
Nucleic Acid Sensing Pathways
Metabolism and the Immune System
Effects of the Microbiota onInflammation and Immunity
Cell Death and Clearance Mechanisms

Take advantage of the early registration discount andsave 10%. Or use the discount codercdvb to register three colleagues for the price of two.

The Anti-Inflammatory Research & Therapeutics Conference is part ofModern Drug Discovery & Development Summit (M3D) which includes five other co-located conferences:

September 9-10, 2015
2nd Cell & Gene Therapy
2nd Biotechnology Transfer & Commercialization
6th Non-Coding RNA & RNAi Therapeutics

September 10-11, 2015
Analytics for Biologics
Protein Kinase Inhibitor Design & Screening
Anti-Inflammatory Research & Therapeutics

Sign up for a summit pass for access to all six tracks!

DISTINGUISHED SPEAKERS

Joost Oppenheim, Chief, Laboratory of Molecular Immunoregulation,National Cancer Insitute, National Institutes of Health - KEYNOTE SPEAKER

Glen Barber, Professor, Hematology & Oncology,University of Miami - FEATURED SPEAKER

Eleonore Beurel, Assistant Professor, Psychiatry,University of Miami

Raymond Birge, Professor, Biochemistry & Molecular Biology, Rutgers University

Michael Bradshaw, Associate Director,Principia Biopharma

Jay Bream, Associate Professor, Molecular Microbiology & Immunology, Johns Hopkins University

Dmitry Gabrilovich, Professor & Program Leader, Translational Tumor Immunology,Wistar Institute

Grant Gallagher, Managing Director & Head, Genetic Immunology,Humigen

Glenn Gerhard, Professor & Chair, Genetics & Molecular Biochemistry, Temple University School of Medicine

Andrew Hu, Associate Professor, Translational Tumor Immunology Program,Wistar Institute

David Huss, Scientist II, Immunology Research,Biogen Idec

Pawel Kalinski, Professor, Surgery; Director, Immunotransplantation Center,University of Pittsburgh

Katia Karalis, Associate Professor, Pediatrics, Biomedical Research Foundation,Academy of Athens

Sergei Kotenko, Professor, Microbiology, Biochemistry & Molecular Genetics,Rutgers University

Laura Mandik-Nayak, Associate Professor,The Lankenau Institute for Medical Research

Kevin Otipoby, Senior Scientist,Biogen Idec

George Prendergast, Professor, President & CEO,Lankenau Institute for Medical Research

Melanie Ruzek, Principal Scientist,AbbVie

Seng-Lai "Thomas" Tan, Director, TIP Immunology, Serono Research and Development Institute, Inc.

Stephanie Watowich, Associate Professor, Immunology,MD Anderson Cancer Center


LAST CALL FOR PAPERS
To be considered for an oral presentation, pleasesubmit an abstract by August 10, 2015. Selected presentations will be based on quality of abstract and availability; the top two abstracts will have the opportunity to give short oral presentations.
SPONSORSHIP & EXHIBITOR OPPORTUNITIES

GTC offers comprehensive sponsorship packages for all our meetings, including presentation opportunities, exhibit and booth space, as well as the event delegate list. All our packages can be customized to meet your company's budget.For more information, please contact
Amber Kempf at 626-256-6405 x110 [e-mail]

UPCOMING CONFERENCES

Results (English) 1:

Anti-inflammatory Research & Therapeutics Conference - Register now to save 10%
Ot кого: "Modern Drug Discovery & Development Summit"
Кому: [e-mail] 28 июля, 18:58 If you Can not View this page, Please Visit: http: //www.gtcbio.com/newsletter/airt15II -w.htm GXOY-2866 5 We do not want Presentations you to Miss! Anti-inflammatory Research & Therapeutics Conference September 10-11, 2015 | Loews Philadelphia Hotel | Philadelphia, PA Speakers | Agenda | Venue | Submit an Abstract | Register Dear Colleague, The Anti-inflammatory Research & Therapeutics Conference is happening Soon onSeptember 10-11, 2015 in Philadelphia, PA. We have designed a comprehensive Program That will field including Cover hot Topics in understanding the mechanisms involved in the pathways and inducing inflammation. Here are some Talks from the agenda: Keynote Presentation - The Anti-Tumor Effects of the HMGN1 Alarmin Joost Oppenheim, Chief of laboratory of Molecular Immunoregulation At NCI, NIH Recent studies have identified a structurally Diverse Group of multifunctional Host Proteins That Challenge or are rapidly released following pathogen Cell Injury and are Able to recruit and activate dendritic AntiGen Both chemotactically-Presenting cells. Dr. Oppenheim will discuss these potent immunostimulants, Called alarmins, That Serve as Warning signals to activate innate and adaptive EARLY immune Systems. Featured Presentation - Innate Immune Signaling and STING- Dependent Role in inflammatory Disease and Cancer Glen Barber, Professor of Cell Biology & Chairman of Sylvester Comprehensive Cancer Center At the University of Miami Miller School of Medicine the The focus of this Presentation will CENTER on STING (stimulator of interferon genes), Signaling Which controls and protects from the Host Disease, and its Potential to Battle against Cancer and DNA mediated inflammation. IDO Pathway in Cancer and Cancer Therapy Immunomodulation of George Prendergast, Professor, Lankenau Institute President & CEO of the Medical Research for Talk discusses studies of indoleamine This 2.3-dioxygenase (IDO) inhibitors to leverage the efficacy of immunomodulators as Powerful immune checkpoint Therapy, radiotherapy or chemotherapy, triggering regression of tumors otherwise resistant to Aggressive Treatment. A foe No More: Reprogramming NF-? B-Driven inflammation in Cancer Therapy Pawel Kalinski, Professor of Surgery and Director of the University of Pittsburgh At the Immunotransplantation Center Dr. Kalinski will discuss different NF-? B-inducible tumor-promoting and tumor Anti-inflammatory pathways and different Strategies for their separation, in Order to ACHIEVE optimal antitumor Effects. Bile Acid Regulation of the Alternative Activation Pathway C3 Glenn Gerhard, Professor & Chair of Medical Molecular Genetics & Biochemistry At Temple University School of Medicine Bile acids are emerging as key mediators of the Beneficial Effects from Bariatric Surgery metabolic. Dr. Gerhard will discuss in proteomic approach to identify the Using a serum complement Play Dual Component System That appears to roles in inflammation and metabolism. Session Topics include: Novel Targets in inflammatory Cytokine Action Nucleic Acid Sensing pathways Metabolism and the Immune System Effects of the microbiota and onInflammation immunity Cell Death Mechanisms and Clearance Take Advantage of the EARLY Registration andsave 10% discount. Or use the discount codercdvb to Register Three Colleagues Two for the price of. The Research & Therapeutics Anti-inflammatory Drug Discovery & Development Conference is Part ofModern Summit (M3D) Which includes co-located Five Other Conferences: September 9-10, 2015 2nd Cell & Gene Therapy Biotechnology Transfer & Commercialization 2nd Non-Coding RNA & RNAi Therapeutics 6th September 10-11, 2015 Analytics for Biologics Protein kinase Inhibitor Design & Screening Anti-inflammatory Research & Therapeutics Sign up for a summit pass for access to all Six tracks ! Distinguished speakers Joost Oppenheim, Chief, Laboratory of Molecular Immunoregulation, National Cancer insitute, National Institutes of Health - KEYNOTE SPEAKER Glen Barber, Professor, Hematology & Oncology, University of Miami - Featured SPEAKER Eleonore Beurel, Assistant Professor, Psychiatry, University of Miami raymond Birge, Professor, Biochemistry & Molecular Biology, Rutgers University Michael Bradshaw, Associate Director, Principia Biopharma Jay Bream, Associate Professor, Molecular Microbiology & Immunology, Johns Hopkins University Dmitry Gabrilovich, Professor & Program Leader, Translational Tumor Immunology, Wistar Institute Grant Gallagher , Managing Director & Head, Genetic Immunology, Humigen Glenn Gerhard, Professor & Chair, Molecular Genetics & Biochemistry, Temple University School of Medicine Andrew Hu, Associate Professor, Translational Tumor Immunology Program, Wistar Institute David Huss, Scientist II, Immunology Research, Biogen Idec Pawel Kalinski, Professor, Surgery; Director, Immunotransplantation Center, University of Pittsburgh Katia Karalis, Associate Professor, Pediatrics, Biomedical Research Foundation, Academy of Athens Sergei kotenko, Professor, Microbiology, Biochemistry & Molecular Genetics, Rutgers University Laura Mandik-Nayak, Associate Professor, Lankenau Institute for Medical The Research Kevin Otipoby, Senior Scientist, Biogen Idec George Prendergast, Professor, President & CEO, Lankenau Institute for Medical Research Melanie Ruzek, Principal Scientist, AbbVie Seng-Lai "Thomas" Tan, Director, TIP Immunology, Serono Research and Development Institute, Inc . Stephanie Watowich, Associate Professor, Immunology, MD Anderson Cancer Center LAST CALL FOR PAPERS To be considered for an oral Presentation, pleasesubmit an Abstract by August 10, 2015. Selected Presentations will be based on Quality of Abstract and availability; the top Two Abstracts will have the OPPORTUNITY to give oral Short Presentations. & exhibitor sponsorship OPPORTUNITIES GTC offers comprehensive sponsorship Packages for all our Meetings, including Presentation opportunities, and exhibit booth SPACE, as Well as the event delegate list. Our Packages Can be Customized to meet all your Company's budget.For more information, Please Contact 626-256-6405 x110 [e-mail] Amber Kempf At Upcoming Conferences